Literature DB >> 23886938

Lats2 phosphorylates p21/CDKN1A after UV irradiation and regulates apoptosis.

Hirokazu Suzuki1, Norikazu Yabuta, Nobuhiro Okada, Kosuke Torigata, Yael Aylon, Moshe Oren, Hiroshi Nojima.   

Abstract

LATS2 (Large tumor suppressor 2), a member of the conserved AGC Ser/Thr (S/T) kinase family, is a human tumor suppressor gene. Here, we show that in response to ultraviolet radiation, Lats2 is phosphorylated by Chk1 at Ser835 (S835), which is located in the kinase domain of Lats2. This phosphorylation enhances Lats2 kinase activity. Subsequently, Lats2 phosphorylates p21 at S146. p21 (CDKN1A) is a cyclin-dependent kinase (CDK) inhibitor, which not only regulates the cell cycle by inhibition of CDK, but also inhibits apoptosis by binding to procaspase-3 in the cytoplasm. Phosphorylation by Lats2 induces degradation of p21 and promotes apoptosis. Accordingly, Lats2 overexpression induces p21 degradation, activation of caspase-3 and caspase-9, and apoptosis. These findings describe a novel Lats2-dependent mechanism for induction of cell death in response to severe DNA damage.

Entities:  

Keywords:  Apoptosis; CDKN1A; Lats2; Phosphorylation; UV; p21

Mesh:

Substances:

Year:  2013        PMID: 23886938     DOI: 10.1242/jcs.125815

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  16 in total

1.  Contribution of LATS1 and LATS2 promoter methylation in OSCC development.

Authors:  Mohammad Ayoub Rigi Ladiz; Maryam Najafi; Dor Mohammad Kordi-Tamandani
Journal:  J Cell Commun Signal       Date:  2016-10-19       Impact factor: 5.782

Review 2.  The Hippo pathway, p53 and cholesterol.

Authors:  Yael Aylon; Moshe Oren
Journal:  Cell Cycle       Date:  2016-07-15       Impact factor: 4.534

3.  Phosphorylation of CHO1 by Lats1/2 regulates the centrosomal activation of LIMK1 during cytokinesis.

Authors:  Ayumi Okamoto; Norikazu Yabuta; Satomi Mukai; Kosuke Torigata; Hiroshi Nojima
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Large tumor suppressor 2, LATS2, activates JNK in a kinase-independent mechanism through ASK1.

Authors:  Lauren Rusnak; Cong Tang; Qi Qi; Xiulei Mo; Haian Fu
Journal:  J Mol Cell Biol       Date:  2018-12-01       Impact factor: 6.216

5.  Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.

Authors:  Liufeng Mei; Yicheng Chen; Zhimeng Wang; Jian Wang; Jiali Wan; Chunrong Yu; Xin Liu; Wenhua Li
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

Review 6.  The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.

Authors:  Noa Furth; Yael Aylon
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

Review 7.  Targeting the Hippo pathway in heart repair.

Authors:  Fansen Meng; Bing Xie; James F Martin
Journal:  Cardiovasc Res       Date:  2022-08-24       Impact factor: 13.081

8.  Binding of Kif23-iso1/CHO1 to 14-3-3 is regulated by sequential phosphorylations at two LATS kinase consensus sites.

Authors:  Didier Fesquet; Geoffroy De Bettignies; Michel Bellis; Julien Espeut; Alain Devault
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

9.  Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition.

Authors:  Nina-Naomi Kreis; Frank Louwen; Brigitte Zimmer; Juping Yuan
Journal:  Oncotarget       Date:  2015-03-30

10.  Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation.

Authors:  Maryam Najafi; Dor Mohammad Kordi-Tamandani; Mohammad Arish
Journal:  J Ophthalmol       Date:  2016-01-28       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.